IRTC
Irhythm Holdings Inc
NASDAQ · Health Care
$146.47
-0.28 (-0.19%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 611.25M | 499.43M | 1.64B | 1.48B | 1.53B |
| Net Income | -117,003,813 | -86,039,244 | 210.47M | 177.25M | 225.68M |
| EPS | — | — | — | — | — |
| Profit Margin | -19.1% | -18.2% | 12.9% | 12.0% | 14.8% |
| Rev Growth | +22.4% | +22.4% | +15.4% | +2.2% | -3.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.07B | 2.07B | 307.61M | 326.12M | 362.93M |
| Total Equity | 290.91M | 290.91M | 2.54B | 2.53B | 2.36B |
| D/E Ratio | 7.11 | 7.11 | 0.12 | 0.13 | 0.15 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -104,441,570 | -81,068,299 | 280.20M | 234.45M | 287.53M |
| Free Cash Flow | — | — | 127.10M | 120.95M | 142.43M |